Fusion Pharmaceuticals Inc. (FUSN) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.63 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback